Diethylstilbestrol-induced immortalization of human endometrial cells: Alterations in p53 and estrogen receptor

Molecular Carcinogenesis

Volumn 15, Issue 2, 1996, Pages 115-123

  Rinehart, Clifford A ^a   Xu, Li Hui ^a   Van Le, Linda ^a,b   Kaufman, David G ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Endometrium; Estrogen; Estrogen receptor; Human; p53; Stromal cells

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL IMMORTALIZATION; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DIETHYLSTILBESTROL; DNA PRIMERS; ENDOMETRIUM; FEMALE; GENE EXPRESSION; GENES, P53; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; TEMPERATURE; TUMOR CELLS, CULTURED;

RODENTIA; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40; TRIXIS;

EID: 0029929701     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199602)15:2<115::AID-MC4>3.0.CO;2-I     Document Type: Article

References (58)

1. Sutton G. Hormonal aspects of endometrial cancer. Curr Opin Obstet Gynecol 2:69-73, 1990.
2. Persson I, Schmidt M, Adami HO, Bergstrom R, Pettersson B, Sparen P. Trends in endometrial cancer incidence and mortality in Sweden, 1960-1984. Cancer Causes Control 1 201-208, 1990
3. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer Lancet 338 274-277, 1991
4. Schlesselman JJ. Oral contraceptives and neoplasia of the uterine corpus. Contraception 43.557-579, 1991
5. Herbst AL, Ulfelder H, Paskanzer DC Adenocarcinoma of the vagina: Association of the maternal stilbestrol therapy with tumor appearance in young women N Engl J Med 284:878-881, 1971
6. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol Cancer Res 40:3988-3999, 1980.
7. Herbst AL, Paskanzer DC, Robboy SJ, Friedlander L, Scully RE. Prenatal exposure to diethylstilbestrol A prospective comparison of exposed female offspring with unexposed controls. N Engl J Med 292 334-339, 1975
8. Barber HRK, Sommers SC Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy Obstet Gynecol 43 645-652, 1974
9. Robboy SJ, Scully RE, Welch WR, Herbst AL Intrauterine diethylstilbestrol exposure and its consequences Arch Pathol Lab Med 101 1-5, 1977
10. Gill WB, Schumacher GFB, Bibbo M. Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero J Urol 117:477-480, 1977.
11. Morse MA, Stoner GD Cancer chemoprevention: Principles and prospects. Carcinogenesis 14 1737-1746, 1993
12. Newbold RR, Bullock BC, McLachlan JA. Uterineadenocarcinoma in mice following developmental treatment with estrogens. A model for hormonal carcinogenesis. Cancer Res 50:7677-7681, 1990.
13. Ozawa N, Oshimura M, McLachlan JA, Barrett JC. Nonrandom karyotypic changes in immortal and tumorigenic Syrian hamster cells induced by diethylstilbestrol. Cancer Genet Cytogenet 38:271-282, 1989
14. Liehr JG, Roy D, Ari-Ulubelen A, Bui QD, Weisz J, Strobel HW Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling Implications for carcinogenesis. J Steroid Biochem Mol Biol 35:550-560, 1990.
15. Weisz J, Bui QD, Roy D, Liehr JG. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: A potential pathway of metabolic activation of estrogens Endocrinology 131:655-661, 1992
16. Ashburn SP, Han X, Liehr JG. Microsomal hydroxylation of 2-and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: Catechol estrogens as possible mediators of hormonal carcinogenesis. Mol Pharmacol 43:534-541, 1993
17. 32P-post labeling in studies of hormonal carcinogenesis. IARC Sci Publ 124 149-155, 1993.
18. Roy D, Bernhardt A, Strobel HW, Liehr JG. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the β-naphtaflavone-inducible cytochrome P450 IA family. Arch Biochem Biophys 296:450-456, 1992.
19. Roy D, Strobel HW, Liehr JG. Cytochrome b5-mediated redox cycling of estrogen Arch Biochem Biophys 285.331-338, 1991
20. 3H)hydride reduction J Biol Chem 266:14446-14450, 1991.
21. Dallenbach-Helleg G. Histopathology of the Endometrium. Springer-Verlag, New York, 1975, pp 22-82.
22. Wynn RM Histology and ultrastructure of the human endometrium In: Wynn RM (ed), Biology of the Uterus Plenum Press, New York, 1977, pp 341-376.
23. Finn CA. The implantation reaction. In: Wynn RM (ed), Biology of the Uterus Plenum Press, New York, 1977, pp. 245-308.
24. Walton LA, Siegfried JM, Nelson KG, Siegal G, Kaufman DG Endometrial stromal cells in culture: An attempt to understand the genesis and biologic activity of uterine sarcomas. Gynecol Oncol 24 247-257, 1986.
25. DiPaolo JA The relative difficulties in transforming human and animal cells in vitro. J Natl Cancer Inst 70:3-24, 1983.
26. Smith JR In vitro cellular aging and immortalization. In. Milo GE, Casto BC, Schuler CF (eds), Transformation of Human Epithelial Cells Molecular and Oncogenetic Mechanisms CRC Press, Boca Raton, FL, 1992, pp 1-7
27. McCormick JJ, Maher VM. Towards an understanding of the malignant transformation of diploid human fibroblasts. Mutat Res 199:273-291, 1988.
28. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621, 1961.
29. Barrett JC, Fletcher WF. In: Barrett JC (ed), Mechanisms of Environmental Carcinogenesis. Multistep Models of Carcinogenesis. CRC Press, Boca Raton, FL, 1987, pp 73-116
30. Christian BJ, Loretz LF, Oberly TD, Reznikoff CA. Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 47:6066-6073, 1987
31. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK, Aaronson SA. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science 227:1250-1252, 1985.
32. Siegfried JM, Nelson KG, Martin JL, Kaufman DG Promotional effect of diethylstilbestrol on human endometrial stromal cells pretreated with a direct-acting carcinogen. Carcinogenesis 5 641-646, 1984
33. Rinehart CA, Laundon CH, Mayben JP, Kaufman DG. Conditional immortalization of human endometrial stromal cells with a temperature-sensitive simian virus 40. Carcinogenesis 14:993-999, 1993
34. Rinehart CA, Haskill JS, Morris JS, Butler TD, Kaufman DG. Extended life span of human endometrial stromal cells transfected with cloned origin-defective, temperature-sensitive simian virus 40. J Virol 65:1458-1465, 1991
35. Gannon JV, Lane DP p53 and DNA polymerease alpha compete for binding to SV40 T antigen Nature 329.456-458, 1987.
36. DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283, 1988.
37. Shay JW, Pereira-Smith OM, Wright WE A role for both RB and p53 in the regulation of human cellular senescence Exp Cell Res 196 33-39, 1991.
38. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells Nature 278:261-263, 1979.
39. Linzer DIH, Levine AJ. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52, 1979
40. Martin RG, Chou JY Simian virus 40 functions required for the establishment and maintenance of malignant transformation J Virol 15-599-612, 1975.
41. Rinehart CA, Carter CA, Xu LH, et al. Transformation of human endometrial stromal cells in vitro. In: Milo GE, Casto BC, Schuler CF (eds), Transformation of Human Epithelial Cells: Molecular and Oncogenetic Mechanisms. CRC Press, Boca Raton, FL, 1992, pp. 85-115.
42. Holinka CF, Hata H, Kuramoto H, Gurpide E. Responses to estradiol in a human endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem 24:85-89, 1986.
43. Chirgwin JM, Przybyla RJ, MacDonald RJ, Rutter WJ Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18.5294-5299, 1979
44. Kawasaki E. Amplification of RNA In: Innis MA (ed), PCR Protocols Academic Press, San Diego, 1990, pp. 21-27
45. Fuqua SAW, Falette NF, McGuire WL. Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay. J Natl Cancer Inst 80:858-861, 1990.
46. Kastner P, Krust A, Turcotte B, et al. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 9.1603-1614, 1990.
47. Scheffner M, Munger K, Byrne JC, Howley PM The state of p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527, 1991.
48. Oren M, Maltzman W, Levine AJ. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol 1:101-110, 1981.
49. Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 3:2143-2150, 1983
50. Lui FS, Kohler MF, Marks JR, Bast RC. Boyd J, Berchuck A. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet Gynecol 83 118-124, 1994.
51. Jiko K, Sasano H, Ito K, Ozawa N, Sato S, Yajima A. Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus. Anticancer Res 13:305-310, 1993.
52. Honda T, Kato H, Imamura T, et al. Involvement of p53 gene mutations in human endometrial carcinomas. Int J Cancer 53:963-967, 1993
53. Enomoto T, Fijita M, Inoue M, et al Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 proto-oncogene in premalignant and malignant lesions of the human uterine endometrium. Cancer Res 53 1883-1888, 1993.
54. Berchuck A, Kohler MF, Marks JR, Wiseman R, Boyd J, Bast RC. The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol 170:246-252, 1994.
55. Yu CC, Wilkinson N, Broto MJ, Buckley CH, Fox H, Levison DA Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium Histopathology 23 367-371, 1993.
56. Kohler MF, Berchuck A, Davidoff AM, et al. Overexpression and mutation of p53 in endometrial cancer Cancer Res 52:1622-1627, 1992
57. Koshiyama M, Konishi I, Wang DP, et al. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas. Inverse correlation with sex steroid receptor status. Virchows Arch A 423:265-271, 1993
58. Xu L-H, Rinehart CA, Kaufman DG Estrogen induced transformation of human endometrial stromal cells Int J Cancer 62 772-776, 1995